Eli Lilly elects Carolyn R. Bertozzi to board as independent director

ELI LILLY & Co

Carolyn R. Bertozzi, Ph.D elected to board effective Dec 8, 2025; will stand for election at May 2026 annual meeting.
Bertozzi is Anne T. and Robert M. Bass Professor of Chemistry at Stanford and HHMI Investigator.
She will serve on Science & Technology Committee and Ethics & Compliance Committee.
Board determined she is independent under NYSE standards and company guidelines.
She will participate in standard director compensation program as described in proxy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.